开窗分支腔内修复术治疗复杂主动脉瘤在八旬老人中安全有效
本研究基于2012至2018年六项前瞻性医生发起的研究器械豁免研究,回顾893例肾旁或I至V型胸腹主动脉瘤患者,比较开窗分支腔内修复术(F-BEVAR)在八旬老人(≥80岁,195例)与非八旬老人(<80岁,698例)中的结局。结果显示两组技术成功率、30天死亡率、主要不良事件及3年靶动脉不稳定与再干预率相似,八旬老人3年生存率较低。
要点
- 八旬老人F-BEVAR技术成功率达99%,30天死亡率仅0.5%,早期结局与非八旬老人相近。
- 八旬老人3年生存率低于非八旬老人,调整活动性肿瘤、高脂血症和慢阻肺后仍成立。
- 在经验丰富的主动脉中心,F-BEVAR可作为八旬老人复杂主动脉瘤的安全有效选择。
核心结论
- F-BEVAR在八旬老人中安全有效,早期结局与非八旬老人几乎相同,但3年生存率较低。
研究设计与样本
- 回顾性分析2012至2018年六项前瞻性医生发起的研究器械豁免研究,共893例肾旁或I至V型胸腹主动脉瘤患者,均接受公司成品或患者定制F-BEVAR支架移植。
- 八旬老人195例(22%),非八旬老人698例(78%)。
主要发现
- 八旬老人活动性肿瘤病史更常见(17% vs 11%;P = .01),非八旬老人高脂血症(76% vs 65%;P = .003)、慢阻肺(42% vs 33%;P = .04)和ASA III至V级(78% vs 70%;P = .02)更常见。
- 八旬老人平均瘤径更大(67 ± 1 mm vs 65 ± 1 mm;P = .002),平均纳入血管数更多(3.1 ± 1.4 vs 2.7 ± 1.7;P < .001)。
- 技术成功率99% vs 97%(P = .19),30天死亡率0.5% vs 1.3%(P = .70),主要不良事件9.2% vs 9.7%,I/III型内漏4.6% vs 2.4%,入路并发症3.1% vs 3.3%,住院时间8.2 ± 27天 vs 5.7 ± 6.3天,均相似。
- 3年免于靶动脉不稳定和免于二次干预率两组相似;八旬老人3年生存率较低(单因素log-rank P < .01),调整活动性肿瘤、高脂血症和慢阻肺后多因素分析仍较低。
临床怎么用
- 在经验丰富的主动脉中心,F-BEVAR可用于八旬老人复杂主动脉瘤的治疗,早期结果与非八旬老人相近。
- 对八旬老人应关注活动性肿瘤等合并症对远期生存的影响,并加强术后随访。
局限性
- 需更多临床经验和更长随访以明确影响远期死亡率的因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Open repair of complex aortic aneurysms is frequently not an option for octogenarians because of prohibitive surgical risks. This study aimed to analyze the outcomes of fenestrated-branched endovascular aortic repair (F-BEVAR) in octogenarians (≥80 years old) compared with nonoctogenarians (<80 years old). METHODS: We reviewed 893 patients with pararenal or extent I to V thoracoabdominal aneurysms, enrolled in six prospective physician-sponsored investigational device exemption studies from 2012 to 2018. All patients were treated with either company-manufactured off-the-shelf or patient-specific F-BEVAR stent grafts. Data analyzed included demographics, cardiovascular risk factors, history of active cancer, American Society of Anesthesiologists classification, aortic anatomy characteristics, and procedural data. End points included mortality, major adverse events (all-cause mortality, stroke, paralysis, acute kidney injury [RIFLE criteria], dialysis, myocardial infarction, respiratory failure, and bowel ischemia), technical success, hospital length of stay, target artery instability (occlusion/stenosis, endoleak, rupture or death), and secondary interventions. RESULTS: During the study period, 195 octogenarian patients (22%) and 698 (78%) nonoctogenarian patients were treated with F-BEVAR. Octogenarians presented more frequently with a history of cancer (17% vs 11%; P = .01), whereas nonoctogenarians more frequently had hyperlipidemia (76% vs 65%; P = .003), chronic obstructive pulmonary disease (42% vs 33%; P = .04) and American Society of Anesthesiologists class III to V (78% vs 70%; P = .02). Male sex was similar between groups (68% [octogenarians] vs 70% [nonoctogenarians]; P = .62). Octogenarians had a larger mean aneurysm diameter (67 ± 1 mm vs 65 ± 1 mm; P = .002). The thoracoabdominal classification and the use of upper extremity access were similar between groups. Estimated blood loss was also similar (484 ± 454 mL [octogenarian] vs 416 ± 457 mL [nonoctogenarian]; P = .07). Octogenarians had an increased mean number of vessels incorporated into the repair (3.1 ± 1.4 vs 2.7 ± 1.7; P < .001). The technical success rate was 99% for octogenarians and 97% for nonoctogenarians (P = .19). The 30-day mortality rate was 0.5% for octogenarians and 1.3% for the nonoctogenarians (P = .70). Major adverse events (9.2% vs 9.7%), types I/III endoleak (4.6% vs 2.4%) access complication (3.1% vs 3.3%), and length of stay (8.2 ± 27 days vs 5.7 ± 6.3 days) were all similar between the groups. Freedom from target artery instability and freedom from secondary interventions at 3 years were similar between the groups. Octogenarian survival was lower at 3 years compared with nonoctogenarians on univariate analysis (log-rank P < .01) and on multivariable analysis after adjusting for history of active cancer, hyperlipidemia, and chronic obstructive pulmonary disease. CONCLUSIONS: Despite small differences in demographics, anatomic factors, and procedural data, F-BEVAR was safe and effective with nearly identical early outcomes in octogenarians in these experienced aortic centers. More extensive clinical experience and longer follow-up are needed to better delineate factors impacting longer term mortality.
引用
- Motta F, Oderich GS, Tenorio ER, et al. Fenestrated-branched endovascular aortic repair is a safe and effective option for octogenarians in treating complex aortic aneurysm compared with nonoctogenarians. J Vasc Surg. 2021. PMID: 33548425. doi:10.1016/j.jvs.2020.12.096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。